Esomeprazole Magnesium
Product Images NDC 71256-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 71256-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cisen Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole Magnesium Structural Formula (Image 01)

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Image 02)

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Image 02)
The figure shows the maintenance of healing rates by month for a study labelled 177, with four different groups represented by four different line plots. The groups are labeled Esomeprazole Magnesium Delayed-release Capsules 40 mg (n=92), Esomeprazole Magnesium Delayed-release Capsules 20 mg (n=98), Esomeprazole Magnesium Delayed-release Capsules 10 mg (n=91), and Placebo (n=94). The x-axis represents the months, and the y-axis represents the percentage of participants who maintained healing within each group.*
FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Image 03)

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Image 03)
The figure shows the maintenance of healing rates over the course of several months for Study 178. It includes three different groups who received varying dosages of Esomeprazole Magnesium Delayed-release Capsules (10mg, 20mg, and 40mg) and one group who received a placebo. The graph displays the percentage of maintained rates for each group.*
FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Image 04)

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Image 04)
This is a graph that shows the percentage of patients who were symptom-free of heartburn after taking either Esomeprazole Magnesium Delayed-release Capsules 40 mg or 20 mg, or a placebo. The graph is divided into different days of the study (day 0 to day 28).*
FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Image 05)

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Image 05)
This is a graph representing the percentage of patients in Study 226 who were symptom-free of heartburn on a daily basis. The graph compares the efficacy of Esomeprazole Magnesium Delayed-release Capsules 40mg and Esomeprazole Magnesium Delayed-release Capsules 20mg with a placebo. The x-axis shows Diary Day while the y-axis represents the Percent of Patients Symptom-Free.*
FDA Label Image

Esomeprazole Magnesium 20 mg 30 Capsules Bottle Label (Image 06)

Esomeprazole Magnesium 20 mg 30 Capsules Bottle Label (Image 06)
This is a description of a medication that comes in 30 delayed-release capsules, with each capsule containing 20mg of Esomeprazole. It's important to keep the container tightly closed and store it between 15-30°C (59-86°F). Dispense the medication in a tight container and follow the usual adult dosage as indicated in the package insert. The medication is manufactured by Cisen Pharmaceutical Co., Ltd, in Jining, Shandong, China.*
FDA Label Image

Esomeprazole Magnesium 20 mg 90 Capsules Bottle Label (Image 07)

Esomeprazole Magnesium 20 mg 90 Capsules Bottle Label (Image 07)
This is a description of medication in capsule form containing 20mg of Esomeprazole. It is important to keep the container closed and store it between 25°C-30°C. The prescription details for adults are available in the package insert. The medicine is supplied in a tight container and the manufacturer is Cisen Pharmaceutical Co., Ltd from Jining, Shandong, China.*
FDA Label Image

Esomeprazole Magnesium Delayed-release Capsules 40 mg 30 Capsules Bottle Label (Image 08)

Esomeprazole Magnesium Delayed-release Capsules 40 mg 30 Capsules Bottle Label (Image 08)
This is a description of a medication, specifically a delayed-release capsule containing 40 mg of esomeprazole magnesium (which is 144.50 mg esomeprazole). The medication should be kept in a tightly closed container and stored at temperatures between 15-30°C (59-86°F). Dispensing should be done in a light container. The usual adult dosage is detailed in the package insert. The capsule container has an NDC number of 71256-004-01 and contains 30 capsules. The medication is manufactured by Cisen Pharmaceutical Co., Ltd. in Shandong, China.*
FDA Label Image

Esomeprazole Magnesium Delayed-release Capsules 40 mg 90 Capsules Bottle Label (Image 09)

Esomeprazole Magnesium Delayed-release Capsules 40 mg 90 Capsules Bottle Label (Image 09)
This is a medication description for delayed-release NDC 71256-004-02 capsules containing 40mg of Esomeprazole magnesium trhydrato, USP, presented as 144.50mg esomeprazole. The medication should be stored at a temperature between 15-30°C (59-86°F) and the container should be kept tightly closed. The instructions advise consulting the package insert for the usual adult dosage, and the medication should be dispensed in a Ugh container. There is a reference to a company called Cisen Pharmaceutical Co., Ltd located in Shandong, China.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.